Results 91 to 100 of about 44,124 (251)

Adenosine-induced non-sustained polymorphic ventricular tachycardia [PDF]

open access: yes, 2017
Adenosine has become widely used because of its diagnostic and therapeutic value in the emergency management of arrhythimias. it produces transient heart block by slowing conduction through tile AV node and thus terminates supraventricular tachycardias ...
CANDINAS, R., ROMER, M.
core  

Supraventricular Tachycardia Ablation in the Elderly—Characteristics and Outcomes

open access: yesJournal of Arrhythmia, Volume 42, Issue 1, February 2026.
This single‐center retrospective study found that supraventricular tachycardia (SVT) ablation is safe and effective in younger and elderly patients. It should be considered for all symptomatic individuals regardless of age. However, the type of SVT and the presence of comorbidities, including frailty, should be considered in the clinical decision ...
Yi Yi Chua   +8 more
wiley   +1 more source

Sotalol in the Treatment of Fetal Tachyarrhythmia [PDF]

open access: yes, 2006
A taquicardia fetal é uma situação rara, que, quando mantida coloca em risco a vida do feto. O modo de tratamento não é consensual, existindo várias modalidades farmacológicas. O objectivo deste estudo foi avaliar a eficácia e segurança do sotalol no
Kaku, S   +4 more
core  

Cost‐utility analysis of radiofrequency ablation versus optimal medical therapy in managing supraventricular tachycardia among Filipinos [PDF]

open access: gold, 2023
Giselle G Gervacio   +6 more
openalex   +1 more source

Suspected pro‐arrhythmic effects of flecainide and the limitations of in‐hospital short‐duration electrocardiography in detecting ventricular arrhythmia burden in a dog with dilated cardiomyopathy

open access: yesVeterinary Record Case Reports, Volume 14, Issue 1, February 2026.
Abstract A 10‐year‐old, female, spayed Pitbull mix presented for evaluation of an arrhythmia. Echocardiography revealed enlargement of all cardiac chambers and decreased left ventricular systolic function. Electrocardiography demonstrated isolated, ventricular premature complexes.
Nathan Mitchell   +3 more
wiley   +1 more source

Utilização do monitor de eventos externo (web-loop) na identificação de sintomas associados a arritmias cardíacas em uma população geral [PDF]

open access: yes, 2014
ObjectiveTo correlate arrhythmic symptoms with the presence of significant arrhythmias through the external event monitoring (web-loop). MethodBetween January and December 2011, the web-loop was connected to 112 patients (46% of them were women, mean age
Borges, Melania Aparecida   +9 more
core   +1 more source

Extrasystoles on 24‐h Holter Monitoring During the First Year of Life

open access: yesActa Paediatrica, Volume 115, Issue 2, Page 370-377, February 2026.
ABSTRACT Aim To assess the natural course of extrasystoles and their association with tachyarrhythmias on 24‐h Holter monitoring during the first year of life. Methods A retrospective chart review was performed among newborns referred for 24‐h Holter monitoring at Tampere University Hospital from 2011 to 2017.
Asta Uusitalo   +5 more
wiley   +1 more source

PROPAFENONE, A NEW EFFECTIVE ANTIARRHYTHMIC DRUG. REPORT OF 2 YEARS CLINICAL EXPERIMENT WITH PROPAFENONE (WITH BRIEF REVIEW OF ARTICLES) [PDF]

open access: yesActa Medica Iranica, 1986
Propafenone HCI (p), is a relatively new Class IC antiarrhythmic agent. It has been reported to be superior to conventional antiarrhythmics in the control of supraventricular, ventricular and WPW associated tachyarrhythmias.
IRAJ NAZERY    +1 more
doaj   +1 more source

Arrhythmias and conduction abnormalities in children after repair of tetralogy of Fallot [PDF]

open access: yes, 2005
Aim. To find out types and frequency of cardiac arrhythmias and conduction abnormalities in the group of children who underwent surgery for tetralogy of Fallot (TOF). Methods. Fortysix pedicatric patients who underwent a complete repair of TOF at the age
Gurkova Beti   +2 more
core   +1 more source

Cardiovascular Challenges in Chronic Lymphocytic Leukemia (CLL) Patients Undergoing Bruton Tyrosine Kinase (BTK) Inhibitor Therapy

open access: yesEuropean Journal of Haematology, Volume 116, Issue 2, Page 104-115, February 2026.
ABSTRACT Background/Objectives Bruton tyrosine kinase inhibitors (BTKis) have revolutionized treatment for chronic lymphocytic leukemia (CLL), but cardiovascular (CV) toxicities pose significant challenges. Second‐generation BTKis offer improved target specificity, yet CV risks persist.
Stefano Oliva, Stefano Molica
wiley   +1 more source

Home - About - Disclaimer - Privacy